SRP3313
IL-17E human
Animal-component free, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC)
Manufacturer: Sigma Aldrich
Synonym(S): IL-25
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 25 μG | SRP3313-25-μG | In Stock | ₹ 39,349.50 |
SRP3313 - 25 μG
In Stock
Quantity
1
Base Price: ₹ 39,349.50
GST (18%): ₹ 7,082.91
Total Price: ₹ 46,432.41
biological source
human
recombinant
expressed in E. coli
Assay
≥98% (HPLC)≥98% (SDS-PAGE)
form
lyophilized
potency
10.0-100.0 ng/mL
mol wt
33.8 kDa
packaging
pkg of 25 μg
impurities
endotoxin, tested
UniProt accession no.
Q9H293
shipped in
wet ice
Related Products
Description
- General description: IL-17E is a disulfide-linked homodimer of two 145 amino acid polypeptide chains. It belongs to the IL-17 family of structurally-related cytokines that share a highly conserved C-terminal region, but differ from one another in their N-terminal regions and in their distinct biological roles. The six known members of this family, IL-17A through IL-17F, are secreted as homodimers. IL-17E stimulated secretion of IL-8, and induces activation of the transcription factor NF-?B in cells that express the IL-17BR receptor. Recombinant human IL-17E is a 33.8 kDa disulfide-linked homodimer of two 146 amino acid polypeptide chains.
- Biochem/physiol Actions: IL-17E is a disulfide-linked homodimer of two 145 amino acid polypeptide chains.
- Physical form: Lyophilized with no additives
- Reconstitution: Centrifuge the vial prior to opening. Reconstitute in water to a concentration of 0.1-1.0 mg/ml. Do not vortex. This solution can be stored at 2-8°C for up to 1 week. For extended storage, it is recommended to further dilute in a buffer containing a carrier protein (example 0.1% BSA) and store in working aliquots at -20°C to -80°C.
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
biological source: human
recombinant: expressed in E. coli
Assay: ≥98% (HPLC)≥98% (SDS-PAGE)
form: lyophilized
potency: 10.0-100.0 ng/mL
mol wt: 33.8 kDa
packaging: pkg of 25 μg
impurities: endotoxin, tested
UniProt accession no.: Q9H293
shipped in: wet ice
biological source:
human
recombinant:
expressed in E. coli
Assay:
≥98% (HPLC)≥98% (SDS-PAGE)
form:
lyophilized
potency:
10.0-100.0 ng/mL
mol wt:
33.8 kDa
packaging:
pkg of 25 μg
impurities:
endotoxin, tested
UniProt accession no.:
Q9H293
shipped in:
wet ice
biological source: human
recombinant: expressed in E. coli
Assay: ≥98% (HPLC)≥98% (SDS-PAGE)
form: lyophilized
potency: 0.7-1.0 ng/mL
mol wt: 33.6 kDa
packaging: pkg of 10 μg
impurities: endotoxin, tested
UniProt accession no.: Q9GZX6
shipped in: wet ice
biological source:
human
recombinant:
expressed in E. coli
Assay:
≥98% (HPLC)≥98% (SDS-PAGE)
form:
lyophilized
potency:
0.7-1.0 ng/mL
mol wt:
33.6 kDa
packaging:
pkg of 10 μg
impurities:
endotoxin, tested
UniProt accession no.:
Q9GZX6
shipped in:
wet ice
biological source: __
recombinant: expressed in E. coli
Assay: ≥98% (HPLC)≥98% (SDS-PAGE)
form: lyophilized
potency: __
mol wt: 19.6 kDa
packaging: __
impurities: endotoxin, tested
UniProt accession no.: P15018
shipped in: wet ice
biological source:
__
recombinant:
expressed in E. coli
Assay:
≥98% (HPLC)≥98% (SDS-PAGE)
form:
lyophilized
potency:
__
mol wt:
19.6 kDa
packaging:
__
impurities:
endotoxin, tested
UniProt accession no.:
P15018
shipped in:
wet ice
biological source: human
recombinant: expressed in CHO cells
Assay: ≥95% (HPLC)≥95% (SDS-PAGE)
form: lyophilized
potency: __
mol wt: 24.4 kDa
packaging: pkg of 20 μg
impurities: endotoxin, tested
UniProt accession no.: Q6UXX9
shipped in: wet ice
biological source:
human
recombinant:
expressed in CHO cells
Assay:
≥95% (HPLC)≥95% (SDS-PAGE)
form:
lyophilized
potency:
__
mol wt:
24.4 kDa
packaging:
pkg of 20 μg
impurities:
endotoxin, tested
UniProt accession no.:
Q6UXX9
shipped in:
wet ice